Iron metabolism in heterozygotes for hemoglobin E (HbE), α-thalassemia 1, or β-thalassemia and in compound heterozygotes for HbE/β-thalassemia

American Journal of Clinical Nutrition

Volumn 88, Issue 4, 2008, Pages 1026-1031

  Zimmermann, Michael B ^a   Fucharoen, Suthat ^b   Winichagoon, Pattanee ^c   Sirankapracha, Pornpan ^b   Zeder, Christophe ^a   Gowachirapant, Sueppong ^c   Judprasong, Kunchit ^c   Tanno, Toshihiko ^d   Miller, Jeffery L ^d   Hurrell, Richard F ^a  

^a ETH ZURICH   (Switzerland)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CITRATE FE 58; FERRITIN; FERROUS SULFATE FE 57; GROWTH DIFFERENTIATION FACTOR 15; GROWTH FACTOR; HEMOGLOBIN E; IRON; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ALPHA THALASSEMIA; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HETEROZYGOTE; HUMAN; IRON ABSORPTION; IRON METABOLISM; MAJOR CLINICAL STUDY; MEAL;

EID: 53849148250     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/88.4.1026     Document Type: Article

References (45)

1. Gordeuk VR, McLaren GD, Samowitz W. Etiologies, consequences, and treatment of iron overload. Crit Rev Clin Lab Sci 1994;31:89-133.
2. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 2001;79:704-12.
3. Angastiniotis M, Modell B. Global epidemiology of haemoglobin disorders. Ann N Y Acad Sci 1998;850:251-69.
4. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption and loading in beta-thalassaemia intermedia. Lancet 1979;2(8147):819-21.
5. Pootrakul P, Sirankapracha P, Hemsorach S, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia. Blood 2000;96:2606-12.
6. Lynch SR, Skikne BS, Cook JD. Food iron absorption in idiopathic hemochromatosis. Blood 1989;74:2187-93.
7. Roe MA, Heath AL, Oyston SL, et al. Iron absorption in male C282Y heterozygotes. Am J Clin Nutr 2005;81:814-21.
8. Heinrich HC, Gabbe EE, Oppitz KH, et al. Absorption of inorganic and food iron in children with heterozygous and homozygous betathalassemia. Z Kinderheilkd 1973;115:1-22.
9. Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption in iron-loading anaemias: effect of subcutaneous desferrioxamine infusions. Lancet 1977;2:737-9.
10. Finch CA, Deubelbeiss K, Cook JD, et al. Ferrokinetics in man. Medicine (Baltimore) 1970;49:17-53.
11. Pippard MJ, Weatherall DJ. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias. Haematologia (Budap) 1984;17:17-24.
12. Kastenmayer P, Davidsson L, Galan P, Cherouvrier F, Hercberg S, Hurrell RF. A double stable isotope technique for measuring iron absorption in infants. Br J Nutr 1994;71:411-24.
13. Walczyk T, Davidson L, Zavaleta N, Hurrell R. Stable isotope labels as a tool to determine the iron absorption by Peruvian school children from a breakfast meal. Fresenius J Anal Chem 1997;359:445-9.
14. Dainty FR, Roe MA, Teucher B, Eagles J, Fairweather-Tait SJ. Quantification of unlabeled nonheme iron absorption in human subjects: a pilot study. Br J Nutr 2003;90:503-6.
15. Singh S, Hider RC, Porter JB. A direct method for quantification of non-transferrin-bound iron. Anal Biochem 1990;186:320-3.
16. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-63.
17. Fiorelli G, Fargion S, Piperno A, Battafarano N, Cappellini MD. Iron metabolism in thalassemia intermedia. Haematologica 1990;75:89-95.
18. Walter PB, Fung EB, Killilea DW, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006;135:254-63.
19. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 2003;102:2670-7.
20. Wickramasinghe SN, Hughes M, Wasi P, Fucharoen S, Litwinczuk RAC. Ultrastructure and cell cycle distribution of erythropoietic cells in heterozygotes and homozygotes for haemoglobin E. Br J Haematol 1984;57:685-94.
21. Wickramasinghe SN, Fucharoen S, Wasi P. Studies of erythropoietic cells in heterozygotes and homozygotes for haemoglobin Constant Spring and in heterozygotes for both haemoglobin Constant Spring and α-thalassaemia 1 trait: extent of globin chain precipitation and cell cycle distribution. Clin Lab Haematol 1986;8:187-98.
22. Pootrakul P, Wattanasaree J, Anuwatanakulchai M, Wasi P. Increased red blood cell protoporphyrin in thalassemia: a result of relative iron deficiency. Am J Clin Pathol 1984;82:289-93.
23. Mazza U, Saglio G, Cappio FC, Camaschella C, Neretto G, Gallo E. Clinical and haematological data in 254 cases of beta-thalassaemia trait in Italy. Br J Haematol 1976;33:91-9.
24. Economidou J, Augustaki O, Georgiopoulou V, Vrettou H, Parcha S, Loucopoulos D. Assessment of iron stores in subjects heterozygous for beta-thalassaemia based on serum ferritin levels. Acta Haematol 1980; 64:205-8.
25. White JM, Richards R, Jelenski G, Byrne M, Ali M. Iron state in alpha and beta thalassaemia trait. J Clin Pathol 1986;39:256-9.
26. Qureshi TZ, Anwar M, Ahmed S, Ahmed Khan D, Saleem M. Serum ferritin levels in carriers of beta-thalassaemia trait. Acta Haematol 1995; 94:7-9.
27. Parfrey PS, Barnett M, Sachs JA, Pollock DJ, Turnbull AL. Iron overload in beta-thalassaemia minor. A family study. Scand J Haematol 1981;27: 294-302.
28. Fargion S, Piperno A, Panaiotopoulos N, Taddei MT, Fiorelli G. Iron overload in subjects with beta-thalassaemia trait: role of idiopathic haemochromatosis gene. Br J Haematol 1985;61:487-90.
29. Mehta BC, Pandya BG. Iron status of beta thalassemia carriers. Am J Hematol 1987;24:137-41.
30. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007;92:583-8.
31. Tassiopoulos T, Konstantopoulos K, Tassiopoulos S, Rombos Y, Alevizou-Terzaki V, Kyriaki P, Loukopoulos D. Erythropoietin levels and microcytosis in heterozygous beta-thalassaemia. Acta Haematol 1997;98:147-9.
32. Demir A, Yarali N, Fisgin T, Duru F, Kara A. Serum transferrin receptor levels in beta-thalassemia trait. J Trop Pediatr. 2004;50:369-71.
33. Hallberg L, Hulten L. Methods to study dietary iron absorption in man-an overview. In: Halberg L, Asp NG, eds. Iron nutrition in health and disease. London, United Kingdom; John Libbey & Co, 1996:81-95.
34. Cook JD, Dassenko SA, Lynch SR. Assessment of the role of nonhemeiron availability in iron balance. Am J Clin Nutr 1991;54:717-22.
35. Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P. Clinical manifestation of beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol 2000;22:552-7.
36. Rees DC. Hemoglobin F and hemoglobin E/beta-thalassemia. J Pediatr Hematol Oncol 2000;22:567-72.
37. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 2005;18:171-82.
38. Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood 2005;105:4103-5.
39. Kattamis A, Papassotiriou I, Palaiologou D, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006;91:809-12.
40. Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007;13:1096-101.
41. WHO/UNICEF/UNU. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva, Switzerland: World Health Organization 2001. (WHO/NHD/01.3, 2001.)
42. Hurrell R. How to ensure adequate iron absoiption from iron-fortified food. Nutr Rev 2002;60:S7-15.
43. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-78.
44. Hallberg L, Hulthen L. Perspectives on iron absorption. Blood Cells Mol Dis 2002;29:562-73.
45. Milman N, Byg KE, Ovesen L, Kirchhoff M, Jürgensen KS. Iron status in Danish women, 1984-1994: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 2003;71:51-61.